Osaic Holdings
JBIO

Osaic Holdings’s Jade Biosciences JBIO Stock Holding History

Osaic Holdings’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
45
-3
-6% -$63 ﹤0.01% 7487
2026
Q1 		$674 Buy
48
+47
+4,700% +$681 ﹤0.01% 7372
2025
Q4 		$15 Buy
+1
New +$12 ﹤0.01% 7749
2025
Q2 		– Hold
0
– -$30 – 7746
2025
Q1 		– Sell
-3
Closed -$264 – 7324
2024
Q4 		$297 Buy
+3
New +$259 ﹤0.01% 7123
2024
Q3 		– Sell
-2
Closed -$115 – 7403
2024
Q2 		$115 Buy
+2
New +$1.33K ﹤0.01% 7234

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's JBIO Position: Q2 2026 in Review

Osaic Holdings reduced its Jade Biosciences (JBIO) stake by 6.3% in Q2 2026, selling an estimated $63 and leaving 45 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #7487.

Osaic Holdings first reported a position in JBIO in Q2 2024 and has held it in 5 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Osaic Holdings held 45 shares of Jade Biosciences worth $1K as of Q2 2026.
  • Osaic Holdings sold 3 Jade Biosciences shares in Q2 2026, an estimated $63.
  • Jade Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7487 holding.
  • Osaic Holdings first reported a position in Jade Biosciences in Q2 2024 and has held it in 5 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.